✦ LIBER ✦

BARD1variants are not associated with breast cancer risk in Australian familial breast cancer

✍ Scribed by Kylie L. Gorringe; David Y. H. Choong; Jane E. Visvader; Geoffrey J. Lindeman; Ian G. Campbell

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 190 KB
Volume: 111
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9799-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic variants within miR-126 and miR-

Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk

✍ Rongxi Yang; Michelle Dick; Frederik Marme; Andreas Schneeweiss; Anne Langheinz; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 220 KB

Association of the ARLTS1 Cys148Arg vari

Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk

✍ Bernd Frank; Kari Hemminki; Alfons Meindl; Barbara Wappenschmidt; Rüdiger Klaes; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 76 KB

## Abstract Recently, __ARLTS1__ (ADP‐ribosylation factor‐like tumor suppressor gene 1) has been identified as a tumor suppressor gene, playing a major role in apoptotic signaling. The ARLTS1 Trp149Stop mutation has been shown to predispose to general familial cancer and high‐risk familial breast c

FAN1variants identified in multiple-case

FAN1variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer

✍ Daniel J. Park; Fabrice A. Odefrey; Fleur Hammet; Graham G. Giles; Laura Bagliet 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 252 KB

Risk of familial breast cancer is not in

Risk of familial breast cancer is not increased after pregnancy

✍ Kari Hemminki; Asta Försti; Jan Sundquist; Jianguang Ji 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 160 KB

ARLTS1, MDM2 and RAD51 gene variations a

ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer

✍ Elif Akisik; Hulya Yazici; Nejat Dalay 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 228 KB

c-MYC Asn11Ser is associated with increa

c-MYC Asn11Ser is associated with increased risk for familial breast cancer

✍ Michael Wirtenberger; Kari Hemminki; Asta Försti; Rüdiger Klaes; Rita K. Schmutz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 98 KB

c-MYC is a multifaceted protein that regulates cell proliferation, differentiation and apoptosis. Its crucial role in diverse cancers has been demonstrated in several studies. Here, we analysed the influence of the rare c-MYC Asn11Ser polymorphism on familial breast cancer risk by performing a case-